לבו ישראל - עברית - Ministry of Health

לבו

unipharm ltd, israel - levofloxacin hemihydrate - טבליה - levofloxacin hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

טאבניק טבליות 500 מג ישראל - עברית - Ministry of Health

טאבניק טבליות 500 מג

sanofi israel ltd - levofloxacin as hemihydrate - טבליות מצופות פילם - levofloxacin as hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity tavanic tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

טאבניק  500 מג תמיסה לאינפוזיה תוך ורידית ישראל - עברית - Ministry of Health

טאבניק 500 מג תמיסה לאינפוזיה תוך ורידית

sanofi - aventis israel ltd - levofloxacin as hemihydrate - תמיסה לאינפוזיה - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

לבופלוקסצין טבע ® 250 מ"ג ישראל - עברית - Ministry of Health

לבופלוקסצין טבע ® 250 מ"ג

teva pharmaceutical indust.ltd - levofloxacin hemihydrate 250 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.

לבופלוקסצין טבע ® 500 מ"ג ישראל - עברית - Ministry of Health

לבופלוקסצין טבע ® 500 מ"ג

teva pharmaceutical indust.ltd - levofloxacin hemihydrate 500 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.

לבו ישראל - עברית - Ministry of Health

לבו

unipharm ltd, israel - levofloxacin as hemihydrate - טבליה - levofloxacin as hemihydrate 500 mg - levofloxacin

לבופלוקס 5 מגמל ישראל - עברית - Ministry of Health

לבופלוקס 5 מגמל

tec-o-pharm-libra ltd - levofloxacin as hemihydrate - תמיסה לאינפוזיה - levofloxacin as hemihydrate 5 mg/ml - levofloxacin

לבופלוקססין פרזניוס 5מגמל ישראל - עברית - Ministry of Health

לבופלוקססין פרזניוס 5מגמל

neopharm (israel) 1996 ltd - levofloxacin as hemihydrate - תמיסה לאינפוזיה - levofloxacin as hemihydrate 5 mg/ml - levofloxacin

לוודסה ישראל - עברית - Ministry of Health

לוודסה

taro international ltd, israel - dexamethasone; levofloxacin - טיפות עיניים - levofloxacin 5 mg / 1 ml; dexamethasone 1 mg / 1 ml - dexamethasone and antiinfectives

ציפרופלוקסצין טבע 500 מג ישראל - עברית - Ministry of Health

ציפרופלוקסצין טבע 500 מג

teva israel ltd - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 500 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.